Deep dive · NYSE: BIO-B
Bio-Rad Laboratories, Inc. stock analysis
Everything behind the call on Bio-Rad Laboratories, Inc. 6 sections, ordered the way risk stacks up: survival first, quality and price in the middle, context last. The Beacon gives you the read. This is where you check the work.
The five reads
Global tape
No overseas listings — BIO-B trades on its home exchange only.
The bottom linestart here
Chart pattern
Above both averages
The 50-day sits above the 200-day
50-day $345.52 · +5.7%
200-day $304.00 · +20.1%
200-day $304.00 · +20.1%
Dividend
0.00%
A rounding error against cash — this is a capital-gains position
Risk flags
1 on watch
5 checks run, 4 clear
beta 0.10 · vol 0% ann.
worst drawdown -20%
worst drawdown -20%
New to this? Every metric carries a plain-English read beside it, and an ⓘ next to a label opens the definition. Anything unfamiliar is also defined at the foot of the page under Glossary.
NYSE · USDMedical Devices
$365.080.00 · 0.00%CLOSED · vol 4
52-week range↑ 49% off low · ↓ 0.0% off high
$244.54now $365.08$365.08
Quote Aug 20, 2026 · 10:24 AM ET
Tape 2026-09-25
Tape 2026-09-25
01
Survival & solvency
and 4 of 5 forensic checks clear.
↳ Plain EnglishBefore anything else: can this company pay its bills? These blocks check the balance sheet, whether your slice of ownership is being diluted, and whether the accounting looks honest.
Piotroski F-score
F 5/9WATCH
Piotroski F-score 5 of 9. Nine pass/fail tests covering profitability, leverage and operating efficiency; seven or more is strong.
Balance sheetSep 27, 2026
Solvency and liquidity ratios
Current ratioshort-term assets against short-term bills5.62×healthy >2
Debt / equityborrowings against shareholder capital0.19
Net debtborrowings in excess of cash on hand$856.30M
Your ownership stake
Share-count growth vs peersLOW DILUTION
38th pctile
Where this name's share-count growth ranks among peers. Lower is less dilutive.
Net buyback yieldSHRINKING
3.67%
Buybacks less new issuance, as a share of market value.
Buyback yieldGROSS
3.63%
Repurchases as a share of market value, before new issuance is netted off.
Diluted vs basic share gapTHIN OVERHANG
0.07%
Options and awards already granted, expressed as the gap between the diluted and basic counts.
Accounting forensicsSEC filings
Red-flag x-rayGRADE A
90 / 100
0 critical · 1 watch · 4 clear of 5 scored tests
Red-flag x-ray · every check, passes included
CheckStatusValueWhat it looks for
Bankruptcy distressCLEARZ 3.49Altman-Z in the Safe · fundamentals
Earnings manipulationCLEARM -2.29M-score in range · fundamentals
LeverageCLEARLTD/E 0.16long-term debt 0.16× equity · fundamentals
Profitability qualityWATCHF 5/9Piotroski F-score 5 of 9 · fundamentals
Filing forensicsCLEAR0 flagsno filing red flags on the latest 10-K · forensic
5 checks, 4 clear and 1 watch. The passes are shown because a score built from five checks means something different from one built from three.
02Refreshed · Sep 27, 2026GOOD · 68/100
Business quality
29% net margin, 10% return on equity, +1% revenue growth, and capital earning 2% against a 6% cost.
↳ Plain EnglishMargins tell you how much of each sales dollar the company keeps. Return on capital tells you whether reinvesting that money creates value. Both are read against what the filings support, not against a target.
Quality score
68 / 100GOOD
Profitability, growth and balance strength scored separately, then blended.
ProfitabilityRefreshed · Sep 27, 2026
Net marginOF EVERY SALES DOLLAR
29.4%
The share of revenue that survives every cost and becomes profit.
Gross marginPRICING POWER
51.9%
What is left of a sales dollar before overhead — the clearest read on pricing power.
Operating marginAFTER RUNNING COSTS
8.5%
What survives the cost of running the whole business.
Return on equityPER $1 OF EQUITY
10.2%
Annual return on each dollar of shareholder equity.
ROIC − WACC spreadDESTROYS VALUE
-4.0pp
Earns 2% on invested capital that costs about 6%. A positive spread means every retained dollar compounds rather than leaks.
Asset growth vs peersIN LINE
66th pctile
The balance sheet grew +13% on the year. Fast asset growth is usually a ramp; occasionally it is the start of an inventory problem.
Growth & relative strength
Trailing return by period
1 month0.0%
3 months+23.1%
6 months+35.9%
Year to date+17.5%
1 year+28.2%
Revenue growth (YoY)GROWING
+0.7%
Revenue against the same period a year ago.
12-1 momentumEX LAST MONTH
+28.2%
Return over the last year excluding the most recent month — the standard momentum factor, which drops the short-term reversal.
Relative-strength rankTOP 12%
88 / 100
Where this name's 3-month return against the S&P 500 ranks across the market — a quarter's standing, not the year's.
Around earningsAug 1, 2019
P(beat next quarter)COHORT BASE RATE
64%
survivor-tilted universe (currently-listed names; large-cap-skewed coverage)
Beat rate · this nameBEAT 3 OF THE LAST 4
3 of 4
Its own record against consensus. 4 prints is a small sample, which is why the cohort rate above carries the probability.
Typical earnings moveData unavailableRealized move magnitudes are not published for this name yet — needs ≥8 measured prints · 0 on file.
Reaction: beat vs missData unavailableThe beat-versus-miss reaction gap is not computed for this name — undetermined — needs ≥12 measured beats.
Consensus bias1.05× COHORT
Persistent
consensus runs low for this name — it routinely clears the bar
Dividends & income
Data unavailableThis company does not pay a dividend. There is no yield, payout ratio or ex-dividend date to show, and the return case rests entirely on capital gains.
Signal
Not an income position.
No dividend is declared, so nothing here contributes to total return except the price. That is a fact about the security, not a criticism of it.
Inventory ledger
Data unavailableNo inventory detail is tagged in this company's filings. The ledger needs the XBRL inventory components, which a business without physical goods does not report.
Segments & geography
Data unavailableRevenue by segment and region is not on file for this name, so product and geographic concentration are not shown.
Pattern reliability · platform-wide cohortSnapshot · Sep 27, 2026
Uptrend · leans bullish
HorizonHigherMedianObservations
10d47%0.0%1,132,432
21d47%-0.1%531,932
63d48%-0.7%170,248
slope +0.12 over 40 bars
Dragonfly doji · leans bullish
HorizonHigherMedianObservations
10d36%0.0%507,560
21d40%0.0%237,486
63d44%0.0%73,638
long lower shadow, open=close near high
Tweezer top · leans bearish
HorizonHigherMedianObservations
10d46%0.0%324,295
21d47%0.0%152,024
63d50%0.0%48,500
matching highs
52w breakout · leans bullish
HorizonHigherMedianObservations
10d43%0.0%195,888
21d46%0.0%91,765
63d52%+0.2%28,677
at/near 52-week high
Rsi overbought · leans bearish
HorizonHigherMedianObservations
10d40%0.0%265,199
21d42%0.0%124,339
63d46%0.0%39,280
RSI 97 ≥ 70
Bollinger squeeze
HorizonHigherMedianObservations
10d43%0.0%764,373
21d45%0.0%357,385
63d47%0.0%112,620
bands at a multi-month tight — breakout pending
03
Price & timing
Price $365.08, RSI 97.
↳ Plain EnglishA multiple is what the market charges for a dollar of this company's earnings, cash or revenue; the trend and the options tape say what the price is doing around it. Together they are the timing picture, not the quality one.
Trend
Above 50 & 2003 OF 3 AVERAGES
50-day $345.52 · 200-day $304.00. Price above both is the structural definition of an uptrend.
The setup right now
Price · 504 sessions2024-09-23 → 2026-09-25
price50-day200-day
How to read this
Up 0.00% on the session.
Follow the solid line: each point is a session close. Compare it to the 50-day average — while price stays above it the short-term trend is up, and a drop below is the first structural warning.
Momentum (RSI-14)OVERBOUGHT
97
030 oversold70 hot100
Where momentum sits on a 0–100 scale. Above 70 is overbought, below 30 oversold; the middle says the move has room either way.
Typical day (ATR-14)±0.0%
$0.00
The average true range — how far this stock moves on an ordinary day. It sets the scale a stop has to clear.
MACDBELOW SIGNAL
-1.64
The short-term trend against its own signal line. The sign is the read; the size is not a target.
Bollinger position50% OF RANGE
Mid band
Where price sits inside its own volatility band. The edges are where a move is stretched, not where it reverses.
Chandelier exitLONG INTACT
$365.08
A volatility-based trailing stop, set a few average ranges below the recent high.
Pivots (classic)R1 $365 · S1 $365
$365.08
The last settled session's range projected forward. Reference levels, not predictions — after a big gap they can sit on the wrong side of the price until the next close.
2026-09-29 · in 2 daysJob Openings (JOLTS)A scheduled macro release. It moves this stock independently of anything the company does.
Setup & oddsNightly
Direction oddsnext 12m
54 / 46cohort n=21,665
A lean, not a forecast. These are the cohort's odds — comparable names over the window — not this stock's own history.
Pullback riskoverstretch read
In line1.00× segment rate · n=80,992
Historically, mid names in this tape state saw a ≥10% pullback within 63 trading days in 79% of cases (n=80,992).
Signal
The odds lean, the stretch qualifies it.
Historically, names tripping 0 validated red flags finished lower 12 months later in 46% of cases (n=21,665) — a survivor-biased floor, not a forecast.
Valuation
Earnings yield vs cashBELOW CASH
-2.93pp
Cash pays more than the earnings yield today, so what you are buying is future growth rather than a current return.
Net cash per shareNET DEBT
$-28.29
Cash less every borrowing, per share. It is the part of the price that is not a claim on future profits.
Multiples
Trailing P/Eearnings already reported44.5×
Price / salesprice against revenue, before any of it becomes profit3.8×
Price / bookprice against the accounting value of the assets1.3×
EV / EBITDAthe multiple an acquirer would pay8.8×
EV / free cash flowenterprise value against the cash the business throws off28.3×
FCF yieldfree cash flow per dollar of market value3.84%
2 of the 6 priced multiples above sit in the richer half of its band. Each priced multiple is read against this stock's own history where a five-year range is on file, so the question is whether today is dear for this name rather than for the market. The multiples are computed separately from the quote above and are not re-priced as it moves, so they can lag it.
Price horizon & timingSep 25, 2026
Measure from a price$
To the 50-day
-5.4%
short-term trend line · $345.52
To the 200-day
-16.7%
primary trend line · $304.00
To the 52-week high
0.0%
highest print of the past year · $365.08
To the 52-week low
-33.0%
lowest print of the past year · $244.54
A typical day (ATR)
$365.08 – $365.08
±$0.00 average true range
Type any price to re-measure every distance from it. Each row is a level this page already states somewhere else, so nothing here is a new number — and none of it is a recommendation to trade at that price.
Gamma map
Data unavailableThis name has no listed options chain, so there is no dealer gamma to map. Regime, flip level, walls and the implied move all need a chain to exist.
Options tape
Data unavailableNo options chain is connected for this ticker. Max pain, the put/call ratio, the implied move and the open-interest ladder all need the chain feed.
0413F quarterly · Form 4 dailyNET SIGNAL 0
Ownership & flow
Institutions hold 0%, short interest is 0.00% of float.
↳ Plain EnglishWho is buying and selling, and what they had to disclose. Institutions file 13F 45 days after quarter end, executives file Form 4 within two days, and Congress discloses under the STOCK Act with a 30–45 day legal lag. Every one of those is a look backwards.
Institutional ownership
0.0%RETAIL-HEAVY
The share held by 13F filers. It describes last quarter's positioning, not today's — filings land up to 45 days after quarter end.
The QTick signal
Data unavailableNo factor in the model scored for this name, so there is no net signal to show. The signal appears once the nightly factor run covers it.
Cross-category read
Data unavailableFewer independent evidence families are ready than the engine's minimum, so there is nothing to check for agreement. A cross-category read over two categories is not a read.
Wall Street
Data unavailableNo sell-side firm publishes research on this name. There is no consensus rating, no price target and no estimate revisions to weigh — for a company this size that is the norm rather than a gap in our data.
Who owns it13F quarterly · Form 4 daily
Insider ownershipOFFICERS & DIRECTORS
98.2%
The share held by the people running the company.
Short interest (float)LIGHT
0.00%
The share of the tradable float sold short.
Dollar volume (ADV)14th PCTILE
$9,492/day
Average dollars traded per day, and where that ranks cross-sectionally. Thin liquidity is a cost you pay on the way out, not just on the way in.
Borrow feeData unavailableWe do not license securities-lending data, so the annualized cost of borrowing shares to short is not something we can show. Short interest and days-to-cover above are the closest read we can source.
The story · news & sentimentRolling window
Why it moved on Sep 25, 2026NONE
0.00%
BIO-B was little changed +0.00% since the last close — no notable catalyst, and the move itself was modest.
Congress
Data unavailableNo congressional trades in this name have been disclosed under the STOCK Act. Lawmakers' disclosed trades cluster heavily in large caps, so an empty list is the usual state.
050 graded callsORDINARY VOLATILITY
Risk & track record
Beta 0.10, 0% annual volatility, a -20% worst drawdown, and 3 of 8 risk surfaces clear.
↳ Plain EnglishWhat owning it does to a portfolio, what the model votes against, and how often our own calls have been right. Every call is graded when it resolves, and the ones still open stay visible.
Max drawdown
-20.4%WORST FALL
The deepest peak-to-trough fall in the measured window. Only hold a position you can watch do this.
What it does to a portfolio5-year window
Beta (vs the market)LOW FIT
0.10
The market explains about 0.1% of its daily moves, so this beta says little about how it tracks the index — most of its movement is its own.
Annualized volatilityORDINARY
0%
How far it swings over a year, from its own realized returns.
What votes against
Data unavailableNo factor in the model currently votes against this name. That is a statement about the model's inputs today, not a claim that nothing could go wrong.
Failure modes · by company type
Data unavailableFailure modes are routed per company type, and only the bank-run and crypto-treasury rulebooks are validated so far. This name routes as unknown, so there is no cohort-specific checklist to run. A generic list would read as analysis without being any.
The risk case · why not to buy8 surfaces · nightly
Suggested position capmax defensible size
3.2%tail cap binds
max defensible size 3.2% - tail binds
Avoid score6-month distress
0.9%0.1× its cohort · names above $5
Observational 6-month large-drawdown risk ranking — not a forecast, not alpha. Historical distress rate for this names above $5 segment: 7.3%. This name reads 0.1× that base rate.
LowDistress screenThe distress model did not score this name in the latest run, so this surface is unmeasured rather than clear.Not scored
MedPosition size, not conviction, is the binding constrainthalf-Kelly 55.0% · tail cap 3.2% · category cap 54.6%. The tail cap binds, so 3.2% is the number (n=140,733). We show which one binds rather than the friendliest.Sizing
LowLottery-ticket behaviourIts best 21-day return sits at 0.0% against a 9.6% cohort 90th-percentile threshold — below the line where forward returns have historically turned negative.Behaviour
LowCash runwayNon-burner: catastrophe rate 6.1% (n=297414).Solvency
LowPost-earnings driftNo measured earnings reaction on file, so the drift surface is unmeasured.Not scored
LowDividend riskNot scored for this name.Not scored
LowRestatement historyFiling history is not deep enough to check for restatements.Not scored
LowCrowded shortNot in a warn state: the crowded-short model only publishes when short interest and thin liquidity coincide, and neither condition is met here.Not scored
Signal
3 of 8 surfaces clear.
8 surfaces checked, 3 clear. The binding constraint is position size — the tail cap is the one that binds. Each row states which surface it is and what it measured; a surface that could not be scored says so rather than counting as clear.
Who should skip it
Skip it if any of these is you
You want income
A 0.00% yield is a rounding error against cash. This is a capital-gains position.
Our track record0 resolved
Track recordBUILDING IN THE OPEN
18 logged
18 calls logged on this name, 0 resolved so far. Calls are logged the moment they are made, so the open ones are public before anyone knows how they turn out, and a hit-rate is not published until enough of them resolve.
Calls on BIO-BTHIS NAME
18
This name's own call count. Too few have resolved to publish a rate over them, so none is shown rather than a rate over 0.
0610-K disclosed linksMEDICAL DEVICES
The wider context
5 mapped peers, 3 connections.
↳ Plain EnglishCompanies do not trade alone. This is the peer set, the supply chain that has to deliver, and the macro variables that move the stock regardless of company news.
Rate sensitivity
-9.8% per +1ppINSUFFICIENT
This is the SECTOR prior, not a measurement of this name — the regression did not clear its own bar. The verdict beside it (neutral) comes from the prior too, so the two agree by construction rather than by evidence.
Versus peersLatest session
Peer set · 5 names
SymbolRelationshipPriceSession
ABTPeer$101.29+0.22%
SYKPeer$272.36+0.97%
MDTPeer$88.64-3.39%
BSXPeer$43.92-1.70%
EWPeer$86.29+0.65%
The mapped peer set and how each traded in the latest session. A peer moving with this name says the move is the sector's; one moving against it says the move is this company's.
Time machineHistory from 2023-06-01
Signal
3 of 4 backward windows are positive.
Look-back returns describe what happened, not what is likely. They are here to set the scale a future move would be measured on.
Macro driversRolling window
Next macro catalystIN 2 DAYS
Job Openings (JOLTS)
2026-09-29. A scheduled release that moves this stock independently of anything the company does.
Events · what moves this stockSep 24, 2026
Initial jobless claimsLittle effect either way
Healthcare demand does not depend on hiring.
Typical for the Healthcare sector
On the day -0.2% · A week later -0.1% · Two weeks later 0.0% · Rose on 6 of 170 report days
Across the last 170 Initial jobless claims reports since Jun 8, 2023, BIO-B moved -0.2% on average on the day and was 0.0% higher two weeks later. The S&P 500 moved 0.0% on those days.
Core PCE (the Fed's gauge) is due in 3 days.
Core PCE (the Fed's gauge)Little effect either wayPeople need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day -0.2% · A week later -0.6% · Two weeks later -0.3% · Rose on 1 of 39 report days
Across the last 39 Core PCE (the Fed's gauge) reports since Jun 28, 2023, BIO-B moved -0.2% on average on the day and was 0.3% lower two weeks later. The S&P 500 moved +0.2% on those days.
FOMC decisionLittle effect either way
Healthcare demand does not depend on rates.
Typical for the Healthcare sector
On the day -0.6% · A week later -0.1% · Two weeks later -0.2% · Rose on 2 of 39 report days
Across the last 39 FOMC decision reports since Jul 1, 2023, BIO-B moved -0.6% on average on the day and was 0.2% lower two weeks later. The S&P 500 moved -0.1% on those days.
On the day +0.7% · A week later +0.7% · Two weeks later +0.8% · Rose on 5 of 39 report days
Across the last 39 Housing starts reports since Jun 20, 2023, BIO-B moved +0.7% on average on the day and was 0.8% higher two weeks later. The S&P 500 moved 0.0% on those days.
Industrial productionLittle effect either way
Healthcare does not track the business cycle.
Typical for the Healthcare sector
On the day +0.2% · A week later +0.8% · Two weeks later +0.2% · Rose on 3 of 39 report days
Across the last 39 Industrial production reports since Jun 15, 2023, BIO-B moved +0.2% on average on the day and was 0.2% higher two weeks later. The S&P 500 moved +0.1% on those days.
Job openings (JOLTS) is due in 2 days.
Job openings (JOLTS)Little effect either wayHealthcare demand does not depend on hiring.
Typical for the Healthcare sector
On the day -0.5% · A week later -0.1% · Two weeks later -0.6% · Rose on 2 of 39 report days
Across the last 39 Job openings (JOLTS) reports since Jul 5, 2023, BIO-B moved -0.5% on average on the day and was 0.6% lower two weeks later. The S&P 500 moved 0.0% on those days.
PCE inflation is due in 3 days.
PCE inflationLittle effect either wayPeople need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day -0.2% · A week later -0.6% · Two weeks later -0.3% · Rose on 1 of 39 report days
Across the last 39 PCE inflation reports since Jun 28, 2023, BIO-B moved -0.2% on average on the day and was 0.3% lower two weeks later. The S&P 500 moved +0.2% on those days.
Producer prices (PPI)Little effect either way
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +0.1% · A week later 0.0% · Two weeks later +0.5% · Rose on 2 of 39 report days
Across the last 39 Producer prices (PPI) reports since Jun 12, 2023, BIO-B moved +0.1% on average on the day and was 0.5% higher two weeks later. The S&P 500 moved +0.3% on those days.
Customer momentum
Data unavailableCustomer momentum needs listed customers that disclose a revenue dependence on this company, and none is on file. The connections below are a different map: competitors and partners, most of them curated rather than filed.
Connections3 links · none confirmed
Direct connections · 3 edges
CompanyRelationSessionProvenance
IQV · Partnerpartner-1.69%Rumored · manual
AMZN · Suppliersupplier+0.12%Rumored · manual
PFE · Competitorcompetitor+0.92%Rumored · manual
0 of 3 edges are named in a filing; the rest come from reporting we have not matched to one yet, and are labelled as such.
Glossary · every term on this page
Survival
Altman Z
Bankruptcy-risk score. Above 3.0 is the safe band.
Piotroski F
Nine pass/fail health tests; 7 or more is strong.
Beneish M
Accrual and growth pattern screen. Clear below −2.22, watch to −1.78, elevated above; a year of very fast revenue growth lifts it by construction.
Merton DTD
Standard deviations of asset value between the company and its debt.
EDF
Default frequency calibrated on what actually happened to similar names.
Price & tape
RSI-14
Momentum gauge 0–100. Above 70 is overbought, below 30 oversold.
ATR
Average true range — the size of a typical day.
VWAP
20-day volume-weighted average price — the average paid over the last month; the page shows no intraday VWAP.
Supertrend
A trend-following stop line. A close through it flips the read.
Chandelier
A trailing stop set a few average ranges below the recent high.
Options & flow
Gamma / GEX
Dealer hedging pressure. Negative gamma amplifies moves both ways.
Call / put wall
The strikes with the heaviest open interest; they act as ceiling and floor.
Max pain
The strike where most options expire worthless.
13F · Form 4
Institutional filings, 45 days after quarter end. Insider trades, within two days.
Scoring
Composite signal
Independent factors scored and netted into one number.
Hit-rate
Share of past calls that resolved in the direction stated.
Brier score
Calibration measure. Lower means stated probabilities track reality.
HHI
Concentration 0–10,000. Above 2,500 means one segment carries the company.
EVT
Fits the tail rather than assuming a bell curve, so bad days are not understated.